Miv Therapeutics, Inc. (IVT) Tops Q3 EPS by 1c

Go back to Miv Therapeutics, Inc. (IVT) Tops Q3 EPS by 1c

InvenTrust Properties Corp. Reports 2025 Third Quarter Results

October 28, 2025 4:03 PM EDT

DOWNERS GROVE, Ill.--(BUSINESS WIRE)-- InvenTrust Properties Corp. (InvenTrust or the Company) (NYSE: IVT) today reported financial and operating results for the quarter ended September 30, 2025. For the three months ended September 30, 2025 and 2024, the Company reported Net Income of $6.0 million, or $0.08 per diluted share, and Net Loss of $0.5 million, or $0.01 per diluted share, respectively.

Third Quarter 2025 Highlights:

Nareit FFO of $0.49 per diluted share Core FFO of $0.47 per diluted share Same Property Net Operating Income (NOI) growth of 6.4% Leased Occupancy as of... More